Global Chemo Graded Nitrile Powder-free Medical Examination Gloves Market to 2030: Rising Cancer Cases Drives Growth - ResearchAndMarkets.com
30 May 2023
DUBLIN--(BUSINESS WIRE)--The "Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Size, Share & Trends Analysis Report By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
'Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Size, Share & Trends Analysis Report By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2023 - 2030'
The global chemo graded nitrile powder-free medical examination gloves market size is expected to reach USD 611.6 million by 2030, expanding at 10.5% CAGR from 2023 to 2030.
Companies Mentioned
Cardinal Health
Ansell Ltd.
The market demand for chemo-graded nitrile powder-free medical examination gloves is likely to increase due to the rising incidence of cancer cases globally. Furthermore, according to WHO, cancer facilities accounted for almost 10 million fatalities in 2020, or roughly one in every six deaths, propelling projected market rise in the coming years.
According to the American Cancer Society, the population's expansion and aging are anticipated to cause 16.3 million cancer deaths and 27.5 million new cases of cancer worldwide by 2040. The burden is expected to increase in the future as a result of risk factors like smoking, eating poorly, being inactive, and having fewer pregnancies in developing countries. Over the projection period, the aforementioned reasons will fuel market demand.
With approximately 10 million recorded deaths from cancer in 2021, it is one of the top causes of death worldwide. In the same year, the WHO South-East Asia region recorded 1.4 million cancer-related fatalities and an estimated 2.2 million new cases, accounting for more than one in ten deaths in the region.
Lung cancer caused 10.6% of all cancer-related deaths, followed by breast cancer (9.4%). Additionally, cervical cancer led to the deaths of 8% of patients, liver cancer of 6.6%, and cancer of the lips and mouth of 6.4% patients. In the upcoming years, rising cancer rates in the Asia-Pacific area will increase demand for chemo-graded, nitrile powder-free medical examination gloves.
The significance of early cancer diagnosis has increased as the number of cancer patients rises yearly. There is an increasing need for chemotherapy as a result of early detection and screening. The market will be driven in the future by this aspect. Owing to this demand, the major producers are focusing on creating excellent chemo-graded nitrile gloves.
Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Report Highlights
The Asia Pacific accounted for a 42.5% market share of the market in 2022 owing to the high cancer prevalence and high mortality rate of the illness in the region. Considering the diverse, densely populated region of Southern, Eastern, and South-Eastern Asia, which is home to 4.2 billion people and hosts 55% of the world's population. 8.2 million new cancer cases and 5.2 million cancer deaths were predicted in the region in 2018, accounting for about half of the cancer burden globally, according to the American Cancer Society. China alone is responsible for 52% of the region's new cancer cases and 55% of its cancer fatalities
India is anticipated to grow at a CAGR of 12.0% over the forecast period, as healthcare expenditure is expanding rapidly, resulting in the improved screening process and cancer treatment in India. For instance, according to the economic report of 2022, India's healthcare expenditure increased from 1.8% of GDP in 2020-2021 to 2.1% in 2021-2022
Germany is expected to grow at a CAGR of 11.4% over the forecast period on account of the presence of advanced infrastructure & technology coupled with government support to revolutionize medical treatment. For instance, by linking pharmacies and hospitals via telematic infrastructures, digitizing healthcare administration, and incentivizing both telemedicine and telehealth activities, the Digitalization and Innovation (Digital Healthcare Act - DVG) integrates digital health into the healthcare landscape
Key Attributes:
Report Attribute
Details
No. of Pages
150
Forecast Period
2022 - 2030
Estimated Market Value (USD) in 2022
$274.7 Million
Forecasted Market Value (USD) by 2030
$611.6 Million
Compound Annual Growth Rate
10.5%
Regions Covered
Global
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage Outlook
3.2. Market Segmentation & Scope
3.3. Penetration & Growth Prospect Mapping
3.4. Industry Value Chain Analysis
3.5. Regulatory Framework
3.6. Chemo-graded Nitrile Powder-free Medical Examination Gloves Market - Market Dynamics
3.6.1. Market Driver Analysis
3.6.2. Market Restraint Analysis
3.6.3. Market Opportunity Analysis
3.7. Industry Analysis Tools: Chemo-graded Nitrile Powder-free Medical Examination Gloves Market
3.8. Economic Mega Trends Analysis
Chapter 4. Chemo-graded Nitrile Powder-free Medical Examination Gloves Market: Regional Estimates & Trend Analysis
Chapter 5. Competitive Landscape
Chapter 6. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/ok8lgq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.